rdf:type |
|
lifeskim:mentions |
umls-concept:C0012634,
umls-concept:C0023779,
umls-concept:C0036186,
umls-concept:C0087111,
umls-concept:C0332835,
umls-concept:C0580822,
umls-concept:C1292733,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594,
umls-concept:C2587213
|
pubmed:issue |
5
|
pubmed:dateCreated |
2009-10-26
|
pubmed:abstractText |
We assessed the efficacy of aggressive lipid controlling therapy (ALCT), which maintains low-density lipoprotein cholesterol (LDL-C) below to 80 mg/dL and LDL/high-density lipoprotein cholesterol (HDL-C) ratio less than 1.5 for preventing postcoronary bypass (CABG) saphenous vein graft (SVG) diseases by using intracoronary angioscopy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1552-6259
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
88
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1440-4
|
pubmed:meshHeading |
pubmed-meshheading:19853088-Anticholesteremic Agents,
pubmed-meshheading:19853088-Coronary Artery Bypass,
pubmed-meshheading:19853088-Female,
pubmed-meshheading:19853088-Fluorobenzenes,
pubmed-meshheading:19853088-Follow-Up Studies,
pubmed-meshheading:19853088-Humans,
pubmed-meshheading:19853088-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19853088-Hyperlipidemias,
pubmed-meshheading:19853088-Male,
pubmed-meshheading:19853088-Middle Aged,
pubmed-meshheading:19853088-Pravastatin,
pubmed-meshheading:19853088-Pyrimidines,
pubmed-meshheading:19853088-Saphenous Vein,
pubmed-meshheading:19853088-Sulfonamides,
pubmed-meshheading:19853088-Vascular Diseases
|
pubmed:year |
2009
|
pubmed:articleTitle |
Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease.
|
pubmed:affiliation |
Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan. mihata@med.nihon-u.ac.jp
|
pubmed:publicationType |
Journal Article
|